Carson Smith
Interventional Cardiology · Cleveland, OHNPI 1932691102
Payments from drug & device makers
Across 122 payments — averaging $62.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Circulation Inc$2K
- Amgen$917
- Abiomed$899
- Abbott$601
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$575
- AstraZeneca$526
- plus $2K from 19 others
Across 1 payment — averaging $140.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abiomed$141
What the payments were for
- Travel & lodging$1,50220%
- Food & beverage$5,56773%
- Education$5497%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Circulation Inc | 10 | $2,226 |
| Amgen | 11 | $917 |
| Abiomed | 17 | $899 |
| Abbott | 7 | $601 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $575 |
| AstraZeneca | 11 | $526 |
| Imperative Care, Inc | 12 | $292 |
| Boston Scientific | 4 | $278 |
| Teleflex LLC | 5 | $227 |
| Chiesi USA, Inc. | 8 | $198 |
| Shockwave Medical, Inc | 3 | $176 |
| Cardiva Medical, Inc. | 6 | $163 |
| Boehringer Ingelheim | 1 | $125 |
| Novo Nordisk | 2 | $88 |
| Actelion Pharmaceuticals US, Inc. | 2 | $71 |
| Pfizer | 3 | $58 |
| Lantheus Medical Imaging, Inc. | 1 | $32 |
| Terumo Medical Corporation | 1 | $31 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $30 |
| Surmodics, Inc. | 1 | $20 |
| Merck | 1 | $19 |
| Inari Medical, Inc. | 1 | $19 |
| Novartis | 1 | $16 |
| Medtronic | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TherOx DS2 Console$2,131
- Catheter$2,131
- Downstream Cartridge$2,131
- Impella$444
- Repatha$330
- ENSITE PRECISION$223
- COROFLOW$162
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$151
- AVVIGO Guidance System$148
- MANTA$146
- ENSITE$145
- JARDIANCE$125
- LifeVest$102
How this compares
$7,617 in reported general payments places this provider in the 50th percentile of 256 interventional cardiology providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $16,859 |
| Atorvastatin Calcium | 25 | $486 |
| ClopidogrelClopidogrel Bisulfate | 22 | $322 |
| Amlodipine Besylate | 19 | $213 |
| Metoprolol Succinate | 11 | $152 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $58 | $16,85916 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 256 interventional cardiology providers in Ohio.
Other interventional cardiology in Cleveland
- Jun LiCleveland$634K
- Rishi PuriCleveland$544K
- Khaled ZiadaCleveland$427K
- Grant ReedCleveland$237K
- Rayji TsutsuiCleveland$195K
- Michael ChenierCleveland$122K
- Paul PoommipanitCleveland$101K
- Bernardo CorteseCleveland$100K
- Santiago GarciaCincinnati$3.6M
- Gary AnselColumbus$3.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.